Corient Private Wealth
TNDM icon

Corient Private Wealth’s Tandem Diabetes Care TNDM Stock Holding History

Corient Private Wealth’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Sell
16,589
-17,152
-51% -$300K ﹤0.01% 2670
2026
Q1 		$637K Buy
33,741
+14,206
+73% +$309K ﹤0.01% 1902
2025
Q4 		$429K Buy
+19,535
New +$353K ﹤0.01% 1949
2025
Q3 		– Sell
-11,800
Closed -$220K – 2683
2025
Q2 		$220K Buy
11,800
+531
+5% +$10.5K ﹤0.01% 2179
2025
Q1 		$216K Buy
11,269
+3,425
+44% +$100K ﹤0.01% 2031
2024
Q4 		$283K Buy
7,844
+962
+14% +$32.5K ﹤0.01% 1924
2024
Q3 		$292K Sell
6,882
-3,428
-33% -$145K ﹤0.01% 2028
2024
Q2 		$415K Buy
10,310
+4
+0% +$167 ﹤0.01% 1741
2024
Q1 		$365K Buy
10,306
+286
+3% +$7.66K ﹤0.01% 1790
2023
Q4 		$296K Buy
+10,020
New +$208K ﹤0.01% 1868
2023
Q2 		– Sell
-6,272
Closed -$255K – 2169
2023
Q1 		$255K Buy
+6,272
New +$260K ﹤0.01% 1680

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Corient Private Wealth's TNDM Position: Q2 2026 in Review

Corient Private Wealth reduced its Tandem Diabetes Care (TNDM) stake by 51% in Q2 2026, selling an estimated $300K and leaving 16,589 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #2670.

Corient Private Wealth first reported a position in TNDM in Q1 2023 and has held it in 11 quarters since. The position peaked at $637K in Q1 2026. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Corient Private Wealth held 16,589 shares of Tandem Diabetes Care worth $250K as of Q2 2026.
  • Corient Private Wealth sold 17,152 Tandem Diabetes Care shares in Q2 2026, an estimated $300K.
  • Tandem Diabetes Care made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2670 holding.
  • Corient Private Wealth first reported a position in Tandem Diabetes Care in Q1 2023 and has held it in 11 quarters since.
  • Corient Private Wealth's Tandem Diabetes Care position peaked at $637K in Q1 2026.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.